Enhanced effects of PPARgamma ligands and RXR selective retinoids in combination to inhibit migration and invasiveness in cancer cells.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Oncology Report

• Publication date

  2009-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.3892/OR_00000327PMID 19288012
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Biological activity and clinical implications of the matrix metalloproteinases.

  2008cited by this paper
• Retinoid metabolism and nuclear receptor responses: New insights into coordinated regulation of the PPAR–RXR complex

  2008cited by this paper
• Modulation of cell growth and PPARgamma expression in human colorectal cancer cell lines by ciglitazone.

  2008cited by this paper
• Peroxisome Proliferator-Activated Receptor &ggr; and Lung Cancer Biology: Implications for Therapy

  2008cited by this paper
• Growth inhibition and proapoptotic activity induction by IIF and valproic acid on RA-resistant leukemia cells.

  2008cited by this paper
• Synergistic Effects of PPARγ Ligands and Retinoids in Cancer Treatment

  2008cited by this paper
• The regulation of matrix metalloproteinases and their inhibitors.

  2008cited by this paper
• 4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells.

  2007cited by this paper
• Peroxisome proliferator-activated receptor gamma and retinoic acid receptor synergistically up-regulate the tumor suppressor PTEN in human promyeloid leukemia cells.

  2007cited by this paper
• Modulators of the structural dynamics of the retinoid X receptor to reveal receptor function

  2007cited by this paper
• Inhibitory effects of retinoic acid and IIF on growth, migration and invasiveness in the U87MG human glioblastoma cell line.

  2007cited by this paper
• Emerging roles of proteases in tumour suppression

  2007cited by this paper
• Peroxisome proliferator-activated receptor-gamma agonists cause growth arrest and apoptosis in human ovarian carcinoma cell lines.

  2007cited by this paper
• Retinoids as differentiating agents in oncology: a network of interactions with intracellular pathways as the basis for rational therapeutic combinations.

  2007cited by this paper
• Peroxisome proliferator-activated receptor structures: ligand specificity, molecular switch and interactions with regulators.

  2007cited by this paper
• RAR and RXR modulation in cancer and metabolic disease

  2007cited by this paper
• Biology of PPAR gamma in cancer: a critical review on existing lacunae.

  2007cited by this paper
• RXR is an essential component of the oncogenic PML/RARA complex in vivo.

  2007cited by this paper
• Synergistic effects of RXR alpha and PPAR gamma ligands to inhibit growth in human colon cancer cells--phosphorylated RXR alpha is a critical target for colon cancer management.

  2007cited by this paper
• Peroxisome proliferator‐activated receptor α–retinoid X receptor agonists induce beta‐cell protection against palmitate toxicity

  2007cited by this paper
• A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.

  2006cited by this paper
• International Union of Pharmacology. LXIII. Retinoid X Receptors

  2006cited by this paper
• The retinoic acid paradox in cancer chemoprevention.

  2006cited by this paper
• Differentiation and growth inhibition mediated via the RXR:PPARgamma heterodimer in colon cancer.

  2006cited by this paper
• International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors

  2006cited by this paper
• The retinoid X receptor-selective retinoid, LGD1069, down-regulates cyclooxygenase-2 expression in human breast cells through transcription factor crosstalk: implications for molecular-based chemoprevention.

  2005cited by this paper
• Synthetic retinoids: recent developments concerning structure and clinical utility.

  2005cited by this paper
• PPAR gamma, 10 years later.

  2005cited by this paper
• Can PPAR gamma ligands be used in cancer therapy?

  2004cited by this paper
• Transactivation of the PPAR-Responsive Enhancer Module in Chemopreventive Glutathione S-Transferase Gene by the Peroxisome Proliferator-Activated Receptor-γ and Retinoid X Receptor Heterodimer

  2004cited by this paper
• A retinoid X receptor (RXR)-selective retinoid reveals that RXR-α is potentially a therapeutic target in breast cancer cell lines, and that it potentiates antiproliferative and apoptotic responses to peroxisome proliferator-activated receptor ligands

  2004cited by this paper
• Antineoplastic effects of peroxisome proliferator-activated receptor gamma agonists.

  2004cited by this paper
• Retinoids and cancer: antitumor effect of ATRA and of a new derivative of retinoic acid, IIF, on colon carcinoma cell lines CaCo-2 and HT-29.

  2004cited by this paper
• Thiazolidinedione, a peroxisome proliferator-activated receptor-gamma ligand, inhibits growth and metastasis of HT-29 human colon cancer cells through differentiation-promoting effects.

  2004cited by this paper
• Effect of a new derivative of retinoic acid on proliferation and differentiation in human neuroblastoma cells.

  2003cited by this paper
• Retinoids and Cancer: Antitumoral Effects of ATRA, 9-cis RA and the New Retinoid IIF on the HL-60 Leukemic Cell Line

  2003cited by this paper
• Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.

  1999cited by this paper

• Unlocking therapeutic potential: Exploring nuclear receptors in brain cancer treatment

  2025cites this paper
• Targeting Nuclear Receptors in Lung Cancer—Novel Therapeutic Prospects

  2022cites this paper
• Nuclear receptors in oral cancer-emerging players in tumorigenesis.

  2022cites this paper
• PPARγ Agonists in Combination Cancer Therapies.

  2019cites this paper
• HVEM has a broader expression than PD-L1 and constitutes a negative prognostic marker and potential treatment target for melanoma

  2019cites this paper
• Efficiency of All-Trans Retinoic Acid on Gastric Cancer: A Narrative Literature Review

  2018cites this paper
• 15-Deoxy-Δ12,14-prostaglandin J2 inhibits migration of human thyroid carcinoma cells by disrupting focal adhesion complex and adherens junction

  2017cites this paper
• Nuclear receptors in cancer — uncovering new and evolving roles through genomic analysis

  2017cites this paper
• Editor’s Highlight: PPAR&bgr;/&dgr; and PPAR&ggr; Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis

  2017cites this paper
• Retinoid X Receptor Ligands with Anti-Type 2 Diabetic Activity.

  2017cites this paper
• Natural and Structure-based RXR Ligand Scaffolds and Their Functions.

  2017cites this paper
• Quercetin metabolites inhibit MMP-2 expression in A549 lung cancer cells by PPAR-γ associated mechanisms.

  2016cites this paper
• Retinoids and PPAR agonists: Promising partners in neurodegenerative diseases?

  2016cites this paper
• Chemotherapy and Chemoprevention by Thiazolidinediones

  2015cites this paper
• Combination of bexarotene and the retinoid CD1530 reduces murine oral-cavity carcinogenesis induced by the carcinogen 4-nitroquinoline 1-oxide

  2014cites this paper
• Pioglitazone and cancer: angel or demon?

  2013cites this paper
• Synergistic effect of retinoic acid and vitamin D analog EB1089-induced apoptosis of hepatocellular cancer cells

  2013cites this paper
• Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis

  2013cites this paper
• The pathogenesis of malaria: a new perspective

  2013cites this paper
• Synergistic effect and mechanism of vitamin A and vitamin D on inducing apoptosis of prostate cancer cells

  2013cites this paper
• Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion

  2012cites this paper
• Retinoids in the treatment of glioma: a new perspective

  2012cites this paper
• The Key to Unlocking the Chemotherapeutic Potential of PPARγ Ligands: Having the Right Combination

  2012cites this paper
• Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells.

  2012cites this paper
• Anti-invasive effects and proapoptotic activity induction by the rexinoid IIF and valproic acid in combination on colon cancer cell lines.

  2012cites this paper
• The retinoid X receptors and their ligands.

  2012cites this paper
• Pharmacological and Toxicological Advances in PPAR-Related Medicines

  2012cites this paper
• Molecular Determinants of Magnolol Targeting Both RXRα and PPARγ

  2011cites this paper
• Global gene expression profiling in early-stage polycystic kidney disease in the Han:SPRD Cy rat identifies a role for RXR signaling.

  2011cites this paper
• Peroxisome proliferator-activated receptors: role of isoform gamma in the antineoplastic effect of iodine in mammary cancer.

  2011cites this paper
• Inhibition of estrogen actions in human gynecological malignancies: new aspects of endocrine therapy for endometrial cancer and ovarian cancer.

  2011cites this paper
• Synthesis and Structure of 9-Bromo-2-fluoro-8-[ethyl, (E)-2-propenoate-3-yl]-6,7-dihydro-5H-benzocycloheptene

  2011cites this paper
• Anticancer Role of PPARγ Agonists in Hematological Malignancies Found in the Vasculature, Marrow, and Eyes

  2010cites this paper
• RXRgamma and PPARgamma ligands in combination to inhibit proliferation and invasiveness in colon cancer cells.

  2010cites this paper
• STRUKTURA, DZIA£ANIE I ROLA RECEPTORA- GAMMA PEROKSYSOMÓW AKTYWOWANEGO

  year unknowncites this paper